Sponsor Pipeline

GELLC (Grupo Español de Leucemia Linfocítica Crónica) Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06926205 CHOP Plus Mosunetuzumab as First Line in Patients With Richter´s Syndrome: a Phase II… Richter Syndrome Recruiting
Get alerts when GELLC (Grupo Español de Leucemia Linfocítica Crónica)'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free